Regeneron Pharmaceuticals, Inc. (LON:0R2M)
559.00
+3.42 (0.61%)
At close: Aug 13, 2025
Regeneron Pharmaceuticals Employees
Regeneron Pharmaceuticals had 15,106 employees as of December 31, 2024. The number of employees increased by 1,656 or 12.31% compared to the previous year.
Employees
15,106
Change (1Y)
1,656
Growth (1Y)
12.31%
Revenue / Employee
683.37K GBP
Profits / Employee
214.35K GBP
Market Cap
42.91B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 15,106 | 1,656 | 12.31% |
Dec 31, 2023 | 13,450 | 1,599 | 13.49% |
Dec 31, 2022 | 11,851 | 1,483 | 14.30% |
Dec 31, 2021 | 10,368 | 1,245 | 13.65% |
Dec 31, 2020 | 9,123 | 1,023 | 12.63% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
Oxford Nanopore Technologies | 1,382 |
HUTCHMED (China) | 1,811 |
Regeneron Pharmaceuticals News
- 9 days ago - Regeneron Pharmaceuticals declares $0.88 dividend - Seeking Alpha
- 9 days ago - These Analysts Increase Their Forecasts On Regeneron Pharmaceuticals After Better-Than-Expected Earnings - Benzinga
- 9 days ago - These Analysts Increase Their Forecasts On Regeneron Pharmaceuticals After Better-Than-Expected Earnings - Benzinga
- 10 days ago - Is Regeneron Pharmaceuticals Gaining or Losing Market Support? - Benzinga
- 12 days ago - Regeneron (REGN) Q2 EPS Jumps 53% - The Motley Fool
- 12 days ago - Regeneron: Rapidly Decreasing Importance Of Eylea - Seeking Alpha
- 12 days ago - Smart Money Is Betting Big In REGN Options - Benzinga
- 12 days ago - Regeneron outlines path to $17B Dupixent annual sales and initiates 10 Lynozyfic registrational trials amid robust Q2 growth - Seeking Alpha